| Trial ID: | L0469 |
| Source ID: | NCT04176536
|
| Associated Drug: |
Bi 764198
|
| Title: |
A Study in People With Normal Kidney Function and People With Reduced Kidney Function to Test How BI 764198 is Processed in the Body
|
| Acronym: |
|
| Status: |
COMPLETED
|
| Study Results: |
NO
|
| Results: |
|
| Conditions: |
Healthy|Chronic Kidney Disease
|
| Interventions: |
DRUG: BI 764198
|
| Outcome Measures: |
Primary: AUC0-∞ (area under the concentration-time curve of the analyte in plasma over the time interval from 0 extrapolated to infinity), Up to 96 hours|Cmax (maximum measured concentration of the analyte in plasma), Up to 96 hours | Secondary: AUC0-tz (area under the concentration-time curve of the analyte in plasma over the time interval from 0 the last quantifiable data point), Up to 96 hours
|
| Sponsor/Collaborators: |
Sponsor: Boehringer Ingelheim
|
| Gender: |
ALL
|
| Age: |
ADULT, OLDER_ADULT
|
| Phases: |
PHASE1
|
| Enrollment: |
28
|
| Study Type: |
INTERVENTIONAL
|
| Study Designs: |
Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT
|
| Start Date: |
2019-12-10
|
| Completion Date: |
2020-11-17
|
| Results First Posted: |
|
| Last Update Posted: |
2020-12-19
|
| Locations: |
CRS Clinical Research Services Kiel GmbH, Kiel, 24105, Germany
|
| URL: |
https://clinicaltrials.gov/show/NCT04176536
|
